In December 2018, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) released its latest earnings announcement, which indicated that losses became smaller relative to the prior year’s level – great news for investors Below, I’ve laid out key growth figures on how market analysts view Tonix Pharmaceuticals Holding’s earnings growth outlook over the next couple of years and whether the future looks brighter. I will be looking at earnings excluding extraordinary items to exclude one-off activities to get a better understanding of the underlying drivers of earnings.
Market analysts’ prospects for the upcoming year seems optimistic, with earnings becoming less negative, arriving at -US$25.0m in 2020.
While it’s informative understanding the rate of growth each year relative to today’s value, it may be more insightful to gauge the rate at which the business is rising or falling every year, on average. The pro of this method is that we can get a bigger picture of the direction of Tonix Pharmaceuticals Holding’s earnings trajectory over the long run, irrespective of near term fluctuations, be more volatile. To calculate this rate, I’ve inserted a line of best fit through analyst consensus of forecasted earnings. The slope of this line is the rate of earnings growth, which in this case is 16%. This means, we can anticipate Tonix Pharmaceuticals Holding will grow its earnings by 16% every year for the next few years.
For Tonix Pharmaceuticals Holding, there are three relevant aspects you should further research:
- Financial Health: Does it have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.
- Management:Have insiders been ramping up their shares to take advantage of the market’s sentiment for TNXP’s future outlook? Check out our management and board analysis with insights on CEO compensation and governance factors.
- Other High-Growth Alternatives: Are there other high-growth stocks you could be holding instead of TNXP? Explore our interactive list of stocks with large growth potential to get an idea of what else is out there you may be missing!
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at email@example.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.